Eckert & Ziegler SE (XTER:EUZ) Additional Paid-In Capital : €68.9 Mil(As of Dec. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Additional Paid-In Capital?

Eckert & Ziegler SE's quarterly additional paid-in capital increased from Jun. 2024 (€67.6 Mil) to Sep. 2024 (€67.9 Mil) and increased from Sep. 2024 (€67.9 Mil) to Dec. 2024 (€68.9 Mil).

Eckert & Ziegler SE's annual additional paid-in capital increased from Dec. 2022 (€66.6 Mil) to Dec. 2023 (€66.9 Mil) and increased from Dec. 2023 (€66.9 Mil) to Dec. 2024 (€68.9 Mil).

Eckert & Ziegler SE Additional Paid-In Capital Historical Data

The historical data trend for Eckert & Ziegler SE's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Additional Paid-In Capital Chart

Eckert & Ziegler SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

54.19

66.16

66.61

66.89

68.90

Eckert & Ziegler SE Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Additional Paid-In Capital	Get a 7-Day Free Trial															66.89	67.19	67.63	67.94	68.90

Eckert & Ziegler SE Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Eckert & Ziegler SE Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Eckert & Ziegler SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

1EUZ:Italy EUZd:UK 0NZY:UK EUZG:Austria

Address

Robert-Rossle-Street 10, Berlin, BB, DEU, 13125

Website

https://www.ezag.com

Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Executives

Dr. Andreas Eckert	Supervisory Board
Frank Perschmann	Supervisory Board
Dr. Hakim Bouterfa	Board of Directors
Prof. Dr. Wolfgang Maennig	Supervisory Board
Dr. Harald Hasselmann	Board of Directors

Eckert & Ziegler SE Headlines

No Headlines